Efficacy and safety of topical 0.1% cannabidiol for managing recurrent aphthous ulcers: a randomized controlled trial - BMC Complementary Medicine and Therapies

United Kingdom News News

Efficacy and safety of topical 0.1% cannabidiol for managing recurrent aphthous ulcers: a randomized controlled trial - BMC Complementary Medicine and Therapies
United Kingdom Latest News,United Kingdom Headlines
  • 📰 BioMedCentral
  • ⏱ Reading Time:
  • 60 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 27%
  • Publisher: 71%

A study published in BMC Complimentary Medicine and Therapies finds that topical 0.1% cannabidiol reduces ulcer size and accelerates healing without any side effects. Thus, it may be appropriate for canker sores patients.

The safety of CBD has been demonstrated in animal and human studies. It has a low adverse effect profile, including when chronically used []. However, there are some reports of sedation and somnolence with CBD use. Prescribing CBD with other sedative drugs, such as opioids and benzodiazepines, can cause severe respiratory depression.

]. Scoring was performed again 24 h later. The subjects and examiner were blinded to which chambers contained CBD. The examiner did the relabeling for statistical analysis.To assess the local and systemic side effects of CBD oral paste after applying it on healthy oral mucosa, 50 healthy subjects were recruited to participate in this study. The subjects were instructed to apply CBD over their lower labial mucosa with a provided calibrated spoon 3 times/day after meals for 7 d.

]. The final estimated total sample size was 60. To compensate for error or loss of subjects during follow-up, based on an anticipated drop-out rate of 15%, a total sample size of 72 subjects were recruited.

None of the subjects experienced or reported an obvious adverse reaction on their oral mucosa. Furthermore, no anaphylactic reactions were observed in the respiratory or circulatory system and no signs of liver dysfunction were reported . The subjects’ vital signs and blood parameters were stable before and after the 7-day CBD intervention .Seventy-two patients were enrolled in this study during September 2021–April 2022. Twenty-four subjects were assigned to each intervention.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

BioMedCentral /  🏆 22. in UK

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Xbox won't feature on E3 2023 show floorXbox won't feature on E3 2023 show floorThe Xbox team has confirmed it won't appear on the E3 show floor for 2023, although it will feature as part of E3 Digital.
Read more »

India floats dedicated tribunal to handle internet offencesIndia floats dedicated tribunal to handle internet offencesConsultation for the long-awaited Digital India Act is finally under way although the draft law's still not been revealed
Read more »

Newcastle get first Premier League win in six as Nick Pope avoids another red cardNewcastle get first Premier League win in six as Nick Pope avoids another red cardNewcastle got their first win in six Premier League outings, although the Magpies and goalkeeper Nick Pope may have got a slice of luck in their 2-1 win over Wolves. Pope, who recently served a sus…
Read more »

Grealish and Haaland showcase Man City bromance as teammate is given hilarious 'Oscar'Grealish and Haaland showcase Man City bromance as teammate is given hilarious 'Oscar'Jack Grealish and Erling Haaland are quickly establishing themselves as Manchester City’s newest bromance, although their teammates aren’t always feeling the benefits. The duo jokingly …
Read more »

Evaluating Germline Testing Panels in Southern African Males With Advanced Prostate CancerEvaluating Germline Testing Panels in Southern African Males With Advanced Prostate CancerBackground: Germline testing for prostate cancer is on the increase, with clinical implications for risk assessment, treatment, and management. Regardless of family history, NCCN recommends germline testing for patients with metastatic, regional, very-high-risk localized, and high-risk localized prostate cancer. Although African ancestry is a significant risk factor for aggressive prostate cancer, due to a lack of available data no testing criteria have been established for ethnic minorities. Patients and Methods: Through deep sequencing, we interrogated the 20 most common germline testing panel genes in 113 Black South African males presenting with largely advanced prostate cancer. Bioinformatic tools were then used to identify the pathogenicity of the variants. Results: After we identified 39 predicted deleterious variants (16 genes), further computational annotation classified 17 variants as potentially oncogenic (12 genes; 17.7% of patients). Rare pathogenic variants included CHEK2 Arg95Ter, BRCA2 Trp31Arg, ATM Arg3047Ter (2 patients), and TP53 Arg282Trp. Notable oncogenic variants of unknown pathogenicity included novel BRCA2 Leu3038Ile in a patient with early-onset disease, whereas patients with FANCA Arg504Cys and RAD51C Arg260Gln reported a family history of prostate cancer. Overall, rare pathogenic and early-onset or familial-associated oncogenic variants were identified in 6.9% (5/72) and 9.2% (8/87) of patients presenting with a Gleason score ≥8 or ≥4 + 3 prostate cancer, respectively. Conclusions: In this first-of-its-kind study of southern African males, we provide support of African inclusion for advanced, early-onset, and familial prostate cancer genetic testing, indicating clinical value for 30% of current gene panels. Recognizing current panel limitations highlights an urgent need to establish testing guidelines for men of African ancestry. We provide a rationale for considering lowering the pathologic diagnostic inclusion criteria and call for furt
Read more »

Indian PM Narendra Modi's government resists recognition for same-sex marriage - court papersIndian PM Narendra Modi's government resists recognition for same-sex marriage - court papersGay sex was decriminalised in 2018 but the topic of same-sex marriage remains highly sensitive, with tensions running high before a Supreme Court hearing on Monday. Leaked documents suggest the government opposes legal recognition.
Read more »



Render Time: 2025-02-24 07:53:15